Your browser doesn't support javascript.
loading
Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection.
Beyer, Marc; Abdullah, Zeinab; Chemnitz, Jens M; Maisel, Daniela; Sander, Jil; Lehmann, Clara; Thabet, Yasser; Shinde, Prashant V; Schmidleithner, Lisa; Köhne, Maren; Trebicka, Jonel; Schierwagen, Robert; Hofmann, Andrea; Popov, Alexey; Lang, Karl S; Oxenius, Annette; Buch, Thorsten; Kurts, Christian; Heikenwalder, Mathias; Fätkenheuer, Gerd; Lang, Philipp A; Hartmann, Pia; Knolle, Percy A; Schultze, Joachim L.
Afiliação
  • Beyer M; Life and Medical Sciences Bonn, Genomics &Immunoregulation, University of Bonn, Bonn, Germany.
  • Abdullah Z; Platform for Single Cell Genomics and Epigenomics at the German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.
  • Chemnitz JM; Institute of Experimental Immunology, University Hospital Bonn, Bonn, Germany.
  • Maisel D; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
  • Sander J; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
  • Lehmann C; Life and Medical Sciences Bonn, Genomics &Immunoregulation, University of Bonn, Bonn, Germany.
  • Thabet Y; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
  • Shinde PV; German Center for Infection Research, partner site Bonn-Cologne, Cologne, Germany.
  • Schmidleithner L; Life and Medical Sciences Bonn, Genomics &Immunoregulation, University of Bonn, Bonn, Germany.
  • Köhne M; Department of Gastroenterology, Hepatology and Infectious Diseases, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Trebicka J; Department of Gastroenterology, Hepatology and Infectious Diseases, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Schierwagen R; Life and Medical Sciences Bonn, Genomics &Immunoregulation, University of Bonn, Bonn, Germany.
  • Hofmann A; Life and Medical Sciences Bonn, Genomics &Immunoregulation, University of Bonn, Bonn, Germany.
  • Popov A; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
  • Lang KS; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
  • Oxenius A; Life and Medical Sciences Bonn, Genomics &Immunoregulation, University of Bonn, Bonn, Germany.
  • Buch T; Institute of Human Genetics, Department of Genomics, Life &Brain Center, University of Bonn, Bonn, Germany.
  • Kurts C; Life and Medical Sciences Bonn, Genomics &Immunoregulation, University of Bonn, Bonn, Germany.
  • Heikenwalder M; Institute of Immunology, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.
  • Fätkenheuer G; Institute of Microbiology, Swiss Federal Institute of Technology Zürich, Zürich, Switzerland.
  • Lang PA; Institute of Laboratory Animal Science, University of Zürich, Schlieren, Switzerland.
  • Hartmann P; Institute of Experimental Immunology, University Hospital Bonn, Bonn, Germany.
  • Knolle PA; Institute of Virology, Technische Universität/Helmholtz Zentrum München, München, Germany.
  • Schultze JL; Division of Chronic Inflammation and Cancer, German Cancer Research Center, Heidelberg, Germany.
Nat Immunol ; 17(5): 593-603, 2016 May.
Article em En | MEDLINE | ID: mdl-26950238
ABSTRACT
Persistent viral infections are characterized by the simultaneous presence of chronic inflammation and T cell dysfunction. In prototypic models of chronicity--infection with human immunodeficiency virus (HIV) or lymphocytic choriomeningitis virus (LCMV)--we used transcriptome-based modeling to reveal that CD4(+) T cells were co-exposed not only to multiple inhibitory signals but also to tumor-necrosis factor (TNF). Blockade of TNF during chronic infection with LCMV abrogated the inhibitory gene-expression signature in CD4(+) T cells, including reduced expression of the inhibitory receptor PD-1, and reconstituted virus-specific immunity, which led to control of infection. Preventing signaling via the TNF receptor selectively in T cells sufficed to induce these effects. Targeted immunological interventions to disrupt the TNF-mediated link between chronic inflammation and T cell dysfunction might therefore lead to therapies to overcome persistent viral infection.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Infecções por HIV / HIV / Fator de Necrose Tumoral alfa / Coriomeningite Linfocítica / Vírus da Coriomeningite Linfocítica Tipo de estudo: Prognostic_studies Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Infecções por HIV / HIV / Fator de Necrose Tumoral alfa / Coriomeningite Linfocítica / Vírus da Coriomeningite Linfocítica Tipo de estudo: Prognostic_studies Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha